methylene blue has been researched along with cyproheptadine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbaş, N; Barlas, A; Küçükhüseyin, C; Oncel, H; Payat, M; Silan, C | 1 |
| Basta, MN | 1 |
1 review(s) available for methylene blue and cyproheptadine
| Article | Year |
|---|---|
Postoperative Serotonin Syndrome Following Methylene Blue Administration for Vasoplegia After Cardiac Surgery: A Case Report and Review of the Literature.
Topics: Cardiac Surgical Procedures; Cyproheptadine; Enzyme Inhibitors; Humans; Hypnotics and Sedatives; Lorazepam; Male; Methylene Blue; Middle Aged; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Rocuronium; Serotonin Antagonists; Serotonin Syndrome; Vasoplegia | 2021 |
1 other study(ies) available for methylene blue and cyproheptadine
| Article | Year |
|---|---|
On the mechanisms of adenosine induced pulmonary vasoconstriction in rats.
Topics: Adenosine; Adrenergic Antagonists; Animals; Cyclooxygenase Inhibitors; Cyproheptadine; Dihydroergotoxine; Endothelium, Vascular; Female; Flavonoids; Ginkgo biloba; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Plant Extracts; Platelet Activating Factor; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Sprague-Dawley; Theophylline; Vasoconstriction | 1997 |